We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




A Novel Nanowell Array Sensor for POC Measurement of Stress Hormones

By LabMedica International staff writers
Posted on 13 Jul 2021
Print article
Image: Artist’s depiction of stress molecules in blood being detected electronically inside nanowells (Photo courtesy of Ella Marushchenko)
Image: Artist’s depiction of stress molecules in blood being detected electronically inside nanowells (Photo courtesy of Ella Marushchenko)
Researchers have constructed a microchip "nanosensor" to measure stress hormones such as cortisol in a dedicated nanowell array, which does not require molecular labels or washing steps.

Investigators at Rutgers University (New Brunswick, NJ, USA) designed a nanowell device based on two electrode probes, which were integrated within the nanowell structure. The electrodes were stacked vertically above one another to minimize the electrode spacing. The electrodes were separated by a 40-nanometer insulator layer within the nanowells, meaning that the counter electrodes were actually integrated into the nanowell structure. This sensor geometry limited the exposed surface area of the electrodes, and, as a result, the amount of probe antibody molecules inside the nanowells, while also enhancing the sensitivity by focusing the electric field into the nanowells.

This functional geometry permitted rapid and low volume (less than five microliters) sensing through activation of the wells with antibodies and monitoring of real-time binding events. A 28-well plate biochip was built on a glass substrate by sequential deposition, patterning, and etching steps to create a stacked nanowell array sensor with an electrode gap of 40 nanometers. Sensor response for cortisol concentrations between one and 15 micrograms per deciliter in buffer solution was recorded, and a limit of detection of 0.5 micrograms per deciliter was achieved.

The nanowell array sensor was used to analyze 65 serum samples from patients with rheumatoid arthritis, and the results were compared to those obtained from the standard enzyme-linked immunosorbent assay (ELISA). The results confirmed that nanowell array sensors could be a promising platform for point-of-care testing, where real-time, laboratory-quality diagnostic results are essential.

"The use of nanosensors allowed us to detect cortisol molecules directly without the need for any other molecules or particles to act as labels," said first author Dr. Reza Mahmoodi, a postdoctoral researcher at Rutgers University. "Our new sensor produces an accurate and reliable response that allows a continuous readout of cortisol levels for real-time analysis. It has great potential to be adapted to non-invasive cortisol measurement in other fluids such as saliva and urine. The fact that molecular labels are not required eliminates the need for large bulky instruments like optical microscopes and plate readers, making the readout instrumentation something you can measure ultimately in a small pocket-sized box or even fit onto a wristband one day."

The nanowell array sensor was described in the June 30, 2021, online edition of the journal Science Advances.

Related Links:
Rutgers University

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Pipet Controller
Stripettor Pro
New
TRAb Immunoassay
Chorus TRAb

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.